Cargando…
90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment
Autores principales: | Fuchs, C, Scheer, C, Wauschkuhn, S, Vollmer, M, Rehberg, S, Meissner, K, Kuhn, SO, Friesecke, S, Abel, P, Gründling, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796974/ http://dx.doi.org/10.1186/2197-425X-3-S1-A88 |
Ejemplares similares
-
Beta-blockers in septic shock: What is new?
por: Lescroart, Mickael, et al.
Publicado: (2022) -
Incidence of pathogen detection in blood cultures of severe sepsis and septic shock patients is higher, if blood cultures were drawn before anti-infective therapy
por: Scheer, CS, et al.
Publicado: (2015) -
Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017) -
Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019) -
Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)